Maria Ekholm (Former)
1 – 10 of 14
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Tamoxifen-predictive value of gene expression signatures in premenopausal breast cancer : data from the randomized SBII:2 trial
Lundgren, Christine LU ; Tutzauer, Julia LU
; Church, Sarah E.
; Stål, Olle
; Ekholm, Maria
LU
; Forsare, Carina
LU
; Nordenskjöld, Bo
; Fernö, Mårten
LU
; Bendahl, Pär Ola
LU
and Rydén, Lisa
LU
(2023)
In Breast Cancer Research
25(1).
- Contribution to journal › Article
-
Mark
Safety profile of trastuzumab-emtansine (T-DM1) with concurrent radiation therapy : A systematic review and meta-analysis
- Contribution to journal › Scientific review
- 2022
-
Mark
PAM50 subtyping and ROR score add long-term prognostic information in premenopausal breast cancer patients
Lundgren, Christine LU ; Bendahl, Pär Ola LU ; Church, Sarah E. ; Ekholm, Maria LU ; Fernö, Mårten LU ; Forsare, Carina LU
; Krüger, Ute
LU
; Nordenskjöld, Bo
; Stål, Olle
and Rydén, Lisa
LU
(2022)
In npj Breast Cancer
8(1).
- Contribution to journal › Article
- 2021
-
Mark
Tumor co-expression of progranulin and sortilin as a prognostic biomarker in breast cancer
Berger, Karoline ; Rhost, Sara ; Rafnsdóttir, Svanheiður ; Hughes, Éamon ; Magnusson, Ylva ; Ekholm, Maria LU ; Stål, Olle ; Rydén, Lisa LU
and Landberg, Göran
LU
(2021)
In BMC Cancer
21(1).
- Contribution to journal › Article
- 2020
-
Mark
Carboplatin dose capping affects pCR rate in HER2-positive breast cancer patients treated with neoadjuvant Docetaxel, Carboplatin, Trastuzumab, Pertuzumab (TCHP)
- Contribution to journal › Article
-
Mark
Tumour-infiltrating lymphocytes as a prognostic and tamoxifen predictive marker in premenopausal breast cancer : data from a randomised trial with long-term follow-up
Lundgren, Christine LU ; Bendahl, Pär Ola LU ; Ekholm, Maria LU ; Fernö, Mårten LU ; Forsare, Carina LU
; Krüger, Ute
LU
; Nordenskjöld, Bo
; Stål, Olle
and Rydén, Lisa
LU
(2020)
In Breast Cancer Research
22(1).
- Contribution to journal › Article
- 2019
-
Mark
Effects of adjuvant tamoxifen over three decades on breast cancer–free and distant recurrence–free interval among premenopausal women with oestrogen receptor–positive breast cancer randomised in the Swedish SBII:2pre trial
Ekholm, M. LU ; Bendahl, P. O. LU ; Fernö, M. LU ; Nordenskjöld, B. ; Stål, O. and Rydén, L. LU
(2019)
In European Journal of Cancer
110.
p.53-61
- Contribution to journal › Article
-
Mark
Agreement between molecular subtyping and surrogate subtype classification: a contemporary population-based study of ER-positive/HER2-negative primary breast cancer
Lundgren, Christine LU ; Bendahl, Pär-Ola LU ; Ehinger, Anna LU
; Hegardt, Cecilia
LU
; Larsson, Christer
LU
; Loman, Niklas
LU
; Malmberg, Martin
LU
; Olofsson, Helena
; Saal, Lao
LU
and Sjoblom, Tobias
, et al.
(2019)
In Breast Cancer Research and Treatment
p.1-9
- Contribution to journal › Article
- 2018
-
Mark
Good adherence to adjuvant endocrine therapy in early breast cancer – a population-based study based on the Swedish Prescribed Drug Register
- Contribution to journal › Article
-
Mark
Prognostic and Predictive Markers in Primary Breast Cancer - Quality Assurance and Long-term Effects of Adjuvant tamoxifen Treatment
(2018)
- Thesis › Doctoral thesis (compilation)